FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jörg Hennenlotter

Research Profile

Disorders

Chemicals & Drugs

Procedures

Immunohistochemistry

Concepts & Ideas

Physiology

Anatomy

Devices

Oligonucleotide Array Sequence Analysis

Co-author Network

Publications

TOP 3
Tilman Todenhöfer; Arnulf Stenzl; Veronika Tews; Stefan Aufderklamm; Michael Esser; Georgios Gakis; Jörg Hennenlotter; Ursula Kuehs; Sarah Mohrhardt; Christian Schwentner
Combined application of cytology and molecular urine markers to improve the detection of urothelial carcinoma.
Judith S Knapp; Mario W Kramer; Soum D Lokeshwar; Christian Schwentner; Arnulf Stenzl; Ulrich Vogel; Jörg Hennenlotter; Axel S Merseburger
Galectin-3 expression in prostate cancer and benign prostate tissues: correlation with biochemical recurrence.
Tilman Todenhöfer; Ulrich Vogel; Arnulf Stenzl; Stefan Aufderklamm; Georgios Gakis; Valentina Gerber; Jörg Hennenlotter; Judith Knapp; Ursula Kühs; Axel Merseburger; Christian Schwentner
Altered expression of farnesyl pyrophosphate synthase in prostate cancer: evidence for a role of the mevalonate pathway in disease progression?

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jörg Hennenlotter (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Tilman Todenhöfer; Arnulf Stenzl; Veronika Tews; Stefan Aufderklamm; Michael Esser; Georgios Gakis; Jörg Hennenlotter; Ursula Kuehs; Sarah Mohrhardt; Christian Schwentner
Combined application of cytology and molecular urine markers to improve the detection of urothelial carcinoma.
Cancer cytopathology 2013;121(5):252-60.
2013: Judith S Knapp; Mario W Kramer; Soum D Lokeshwar; Christian Schwentner; Arnulf Stenzl; Ulrich Vogel; Jörg Hennenlotter; Axel S Merseburger
Galectin-3 expression in prostate cancer and benign prostate tissues: correlation with biochemical recurrence.
World journal of urology 2013;31(2):351-8.
2013: Tilman Todenhöfer; Ulrich Vogel; Arnulf Stenzl; Stefan Aufderklamm; Georgios Gakis; Valentina Gerber; Jörg Hennenlotter; Judith Knapp; Ursula Kühs; Axel Merseburger; Christian Schwentner
Altered expression of farnesyl pyrophosphate synthase in prostate cancer: evidence for a role of the mevalonate pathway in disease progression?
World journal of urology 2013;31(2):345-50.
2013: Bastian Amend; Aristotelis G Anastasiadis; Jörg Hennenlotter; Ursula Kuehs; I Laible; David Schilling; Arnulf Stenzl; Karl-Dietrich Sievert
Prostatic peripheral nerve distribution may impact the functional outcome of nerve-sparing prostatectomy.
World journal of urology 2013;31(2):377-82.
2013: Hossein Tezval; Sandra Waalkes; Arnulf Stenzl; Faranaz Atschekzei; Jan U Becker; Jörg Hennenlotter; Markus A Kuczyk; Axel S Merseburger; Inga Peters; Jürgen Serth
Reduced mrna expression level of corticotropin-releasing hormone-binding protein is associated with aggressive human kidney cancer.
BMC cancer 2013;13():199.
2013: J Mundhenk; S Alloussi; Jörg Hennenlotter; Stephan Kruck; J C Martzog; Christian Schwentner; D Selbherr; Arnulf Stenzl; T Todenhöfer; David Schilling
Influence of body mass index, surgical approach and lymphadenectomy on the development of symptomatic lymphoceles after radical prostatectomy.
Urologia internationalis 2013;90():270-6.
2013: Tilman Todenhöfer; Arnulf Stenzl; Stefan Aufderklamm; Georgios Gakis; Miriam Germann; Jörg Hennenlotter; Ursula Kühs; Christian Schwentner
Individual risk assessment in bladder cancer patients based on a multi-marker panel.
Journal of cancer research and clinical oncology 2013;139(1):49-56.
2013: Tilman Todenhöfer; Arnulf Stenzl; Stefan Aufderklamm; Gunnar Blumenstock; Hans-Jörg Bühring; Tanja Fehm; Georgios Gakis; Sabrina Grimm; Jörg Hennenlotter; Andrea Hohneder; Ursula Kühs; Helmut R Salih; David Schilling; Benjamin Joachim Schmiedel; Christian Schwentner
Alterations of the RANKL pathway in blood and bone marrow samples of prostate cancer patients without bone metastases.
The Prostate 2013;73(2):162-8.
2012: Marcus Horstmann; Ursula Kuehs; Heidi Schmid; Arnulf Stenzl; Ulrich Vogel; Lisa M Geiger; Jörg Hennenlotter; Jens Bedke
Evaluation of the KIT/stem cell factor axis in renal tumours.
Anticancer research 2012;32(10):4339-45.
2012: David Schilling; Christian Schwentner; Georgios Gakis; Jörg Hennenlotter; Ursula Kuehs; Arnulf Stenzl; Karl Sotlar
Prospective assessment of histological serial sectioning of pelvic lymph nodes in prostate cancer: a cost-benefit analysis.
BJU international 2012;110(6 Pt B):E166-71.
2012: Tilman Todenhöfer; Arnulf Stenzl; Stefan Aufderklamm; Jasmin Fetisch; Susan Feyerabend; Valentina Gerber; Siegfried Hauch; Jörg Hennenlotter; Ursula Kühs; Johannes Mischinger; David Schilling; Christian Schwentner
Preliminary experience on the use of the Adnatest® system for detection of circulating tumor cells in prostate cancer patients.
Anticancer research 2012;32(8):3507-13.
2012: Stefan Aufderklamm; Johannes Dlugosch; Georgios Gakis; Valentina Gerber; Jörg Hennenlotter; Joachim Hevler; Judith Knapp; Ursula Kuehs; Axel S Merseburger; Anna Ordelheide; David Schilling; Arnulf Stenzl; Tilman Todenhoefer; Ulrich Vogel; Christian Schwentner
XPA-210: a new proliferation marker determines locally advanced prostate cancer and is a predictor of biochemical recurrence.
World journal of urology 2012;30(4):547-52.
2012: Marcus Horstmann; Stephan Kruck; Ursula Kuehs; Axel S Merseburger; H Schmid; Arnulf Stenzl; Ulrich Vogel; L M Geiger; Jörg Hennenlotter; Jens Bedke
Kidney-specific cadherin correlates with the ontogenetic origin of renal cell carcinoma subtypes: an indicator of a malignant potential?
World journal of urology 2012;30(4):525-31.
2012: Inga Peters; Arnulf Stenzl; Wolfgang Tränkenschuh; Sandra Waalkes; Faranaz Atschekzei; Hendrik Eggers; Anika Grosshennig; Jörg Hennenlotter; Markus A Kuczyk; Axel S Merseburger; Jürgen Serth
GATA5 CpG island methylation in renal cell cancer: a potential biomarker for metastasis and disease progression.
BJU international 2012;110(2 Pt 2):E144-52.
2012: Melanie Widenmeyer; Alexei Y Sazykin; Arnulf Stenzl; Stefan Stevanović; Dorothee Wernet; Sebastian Attig; Susan Feyerabend; Cécile Gouttefangeas; Heinrich Griesemann; Jörg Hennenlotter; Reinhild Klein; Dmitri V Kuprash; Steve Pascolo; Hans-Georg Rammensee
Promiscuous survivin peptide induces robust CD4+ T-cell responses in the majority of vaccinated cancer patients.
International journal of cancer. Journal international du cancer 2012;131(1):140-9.
2012: Bastian Amend; Jörg Hennenlotter; Stephan Kruck; Markus A Kuczyk; Ursula Kuehs; Axel S Merseburger; M Scharpf; E Senger; Karl-Dietrich Sievert; Arnulf Stenzl; Jens Bedke
Akt signalling parameters are different in oncocytomas compared to renal cell carcinoma.
World journal of urology 2012;30(3):353-9.
2012: Faranaz Atschekzei; Thilo Dörk; Annika Großhennig; Jörg Hennenlotter; Stefanie Jänisch; Markus A Kuczyk; Axel S Merseburger; Inga Peters; Arnulf Stenzl; Wolfgang Tränkenschuh; Sandra Waalkes; Jürgen Serth
SFRP1 CpG island methylation locus is associated with renal cell cancer susceptibility and disease recurrence.
Epigenetics : official journal of the DNA Methylation Society 2012;7(5):447-57.
2012: Stephan Kruck; Axel S Merseburger; Marcus Scharpf; Karl-Dietrich Sievert; Arnulf Stenzl; Bastian Amend; Christian Eyrich; Jörg Hennenlotter; Jens Bedke
High cytoplasmic expression of p27(Kip1) is associated with a worse cancer-specific survival in clear cell renal cell carcinoma.
BJU international 2012;109(10):1565-70.
2012: Tilman Todenhöfer; Arnulf Stenzl; Veronika Tews; Stefan Aufderklamm; Georgios Gakis; Jörg Hennenlotter; Ursula Kühs; Christian Schwentner
Influence of urinary tract instrumentation and inflammation on the performance of urine markers for the detection of bladder cancer.
Urology 2012;79(3):620-4.
2012: Stephan Kruck; Ursula Kuehs; David Schilling; Georgios Gakis; Jörg Hennenlotter; Joachim Hevler; Arnulf Stenzl; Ulrich Vogel; Christian Schwentner
Exposed proliferation antigen 210 (XPA-210) in renal cell carcinoma (RCC) and oncocytoma: clinical utility and biological implications.
BJU international 2012;109(4):634-8.
2012: Martin Heni; Jörg Hennenlotter; Ursula Kühs; Stefan Z Lutz; Fausto Machicao; Marcus Scharpf; David Schilling; Christian Schwentner; Harald Staiger; Valentina Gerber; Hans-Ulrich Häring; Tilman Todenhöfer; Arnulf Stenzl
Insulin receptor isoforms A and B as well as insulin receptor substrates-1 and -2 are differentially expressed in prostate cancer.
PloS one 2012;7(12):e50953.
2012: Tilman Todenhöfer; Claus Hann von Weyhern; Stefan Wirths; Arnulf Stenzl; Stefan Heckl; Jörg Hennenlotter; Marius Horger; Lothar Kanz; Christian Schwentner
Severe paraneoplastic hypereosinophilia in metastatic renal cell carcinoma.
BMC urology 2012;12():7.
2011: Stephan Kruck; Axel S Merseburger; Aristoteles G Anastasiadis; Georgios Gakis; Jörg Hennenlotter; Arnulf Stenzl; Ute Walcher; Udo Nagele
Flow matters: irrigation flow differs in flexible ureteroscopes of the newest generation.
Urological research 2011;39(6):483-6.
2011: Georgios Gakis; Jörg Hennenlotter; Joachim Hevler; Ursula Kuehs; Marcus Scharpf; David Schilling; Arnulf Stenzl; Christian Schwentner
XPA-210: a new proliferation marker to characterize tumor biology and progression of renal cell carcinoma.
World journal of urology 2011;29(6):801-6.
2011: Jörg Hennenlotter; Ursula Kuehs; Markus Renninger; Christine Springer; Arnulf Stenzl; Ulrich Vogel; Bastian Amend; Jens Bedke
Differential Akt signalling in non-seminomatous testicular germ cell tumors.
Anticancer research 2011;31(11):3783-8.
2011: Matthias C Roethke; David Schilling; Arnulf Stenzl; Ulrich Vogel; Claus D Claussen; Jörg Hennenlotter; Leo Jurgschat; Matthias P Lichy; Heinz-Peter Schlemmer
Tumorsize dependent detection rate of endorectal MRI of prostate cancer--a histopathologic correlation with whole-mount sections in 70 patients with prostate cancer.
European journal of radiology 2011;79(2):189-95.
2011: Stephan Kruck; Jörg Hennenlotter; Thomas Herrmann; Markus Sonnleithner; Arnulf Stenzl; Ute Walcher; Udo Nagele
Interventional stress in renal stone treatment.
Journal of endourology / Endourological Society 2011;25(6):1069-73.
2011: Sandra Waalkes; Hendrik Eggers; Hanna Blasig; Faranaz Atschekzei; Mario W Kramer; Jörg Hennenlotter; Wolfgang Tränkenschuh; Arnulf Stenzl; Jürgen Serth; Andres J Schrader; Markus A Kuczyk; Axel S Merseburger
Caveolin 1 mRNA is overexpressed in malignant renal tissue and might serve as a novel diagnostic marker for renal cancer.
Biomarkers in medicine 2011;5(2):219-25.
2011: Stephan Kruck; Axel S Merseburger; Bastian Amend; Jens Bedke; Jörg Hennenlotter; Arnulf Stenzl; Karl-Dietrich Sievert
Virtual bladder tumor transurethral resection: an objective evaluation tool to overcome learning curves with and without photodynamic diagnostics.
Urologia internationalis 2011;87(2):138-42.
2011: Mario Wolfgang Kramer; Markus A Kuczyk; Jörg Hennenlotter; Jürgen Serth; Arnulf Stenzl; Hossein Tezval; Sandra Waalkes; Axel S Merseburger
Decreased galectin-8 is a strong marker for recurrence in urothelial carcinoma of the bladder.
Urologia internationalis 2011;87(2):143-50.
2011: Daniela Colleselli; Jörg Hennenlotter; Stefan A Krueger; Ursula Kuehs; Matthias P Lichy; Mathias Roethke; David Schilling; Heinz-Peter Schlemmer; Arnulf Stenzl; Ullrich Vogel; Christian Schwentner
Impact of clinical parameters on the diagnostic accuracy of endorectal coil MRI for the detection of prostate cancer.
Urologia internationalis 2011;86(4):393-8.
2011: Juliane S Stickel; Natalie Stickel; Jörg Hennenlotter; Karin Klingel; Arnulf Stenzl; Hans-Georg Rammensee; Stefan Stevanović
Quantification of HLA class I molecules on renal cell carcinoma using Edman degradation.
BMC urology 2011;11():1.
2010: Mesut Remzi; Alexander Haese; Hein Van Poppel; Alexandre de la Taille; Arnulf Stenzl; Jörg Hennenlotter; Michael Marberger
Follow-up of men with an elevated PCA3 score and a negative biopsy: does an elevated PCA3 score indeed predict the presence of prostate cancer?
BJU international 2010;106(8):1138-42.
2010: David Schilling; Jörg Hennenlotter; Karl Sotlar; Ursula Kuehs; Erika Senger; Udo Nagele; Ulf Boekeler; Anja Ulmer; Arnulf Stenzl
Quantification of tumor cell burden by analysis of single cell lymph node disaggregates in metastatic prostate cancer.
The Prostate 2010;70(10):1110-8.
2010: Christoph Thomas; Bernhard Krauss; Dominik Ketelsen; Ilias Tsiflikas; Anja Reimann; Matthias Werner; David Schilling; Jörg Hennenlotter; Claus D Claussen; Heinz-Peter Schlemmer; Martin Heuschmid
Differentiation of urinary calculi with dual energy CT: effect of spectral shaping by high energy tin filtration.
Investigative radiology 2010;45(7):393-8.
2010: Marcus Horstmann; Heike Bontrup; Jörg Hennenlotter; Dirk Taeger; Anne Weber; Beate Pesch; Gerhard Feil; Oliver Patschan; Georg Johnen; Arnulf Stenzl; Thomas Brüning
Clinical experience with survivin as a biomarker for urothelial bladder cancer.
World journal of urology 2010;28(3):399-404.
2010: Sandra Waalkes; Perikles Simon; Jörg Hennenlotter; Judith Knapp; Hossein Tezval; Jürgen Serth; Arnulf Stenzl; Markus A Kuczyk; Axel S Merseburger
Altered expression of Akt signaling pathway parameters in prostate needle biopsies derived from benign, adjacent and cancerous tissue.
Oncology reports 2010;23(5):1257-60.
2010: David Schilling; Theo M de Reijke; Bertrand Tombal; Alexandre de la Taille; Jörg Hennenlotter; Arnulf Stenzl
The Prostate Cancer gene 3 assay: indications for use in clinical practice.
BJU international 2010;105(4):452-5.
2010: Sandra Waalkes; Faranaz Atschekzei; Mario W Kramer; Jörg Hennenlotter; Gesa Vetter; Jan U Becker; Arnulf Stenzl; Axel S Merseburger; Andres J Schrader; Markus A Kuczyk; Jürgen Serth
Fibronectin 1 mRNA expression correlates with advanced disease in renal cancer.
BMC cancer 2010;10():503.
2010: David Schilling; Jörg Hennenlotter; Marita Munz; Ulf Bökeler; Karl-Dietrich Sievert; Arnulf Stenzl
Interpretation of the prostate cancer gene 3 in reference to the individual clinical background: implications for daily practice.
Urologia internationalis 2010;85(2):159-65.
2010: Daniela Colleselli; David Schilling; Matthias P Lichy; Jörg Hennenlotter; Ulrich H Vogel; Stephan A Krueger; Ursula Kuehs; Heinz-Peter Schlemmer; Arnulf Stenzl; Christian Schwentner
Topographical sensitivity and specificity of endorectal coil magnetic resonance imaging for prostate cancer detection.
Urologia internationalis 2010;84(4):388-94.
2010: Stephan Kruck; Jens Bedke; Jörg Hennenlotter; Petra A Ohneseit; Ursula Kuehs; Erika Senger; Karl-Dietrich Sievert; Arnulf Stenzl
Activation of mTOR in renal cell carcinoma is due to increased phosphorylation rather than protein overexpression.
Oncology reports 2010;23(1):159-63.
2010: Mario W Kramer; Roozbeh Golshani; Axel S Merseburger; Judith Knapp; Alfredo Garcia; Jörg Hennenlotter; Robert Duncan; Mark S Soloway; Merce Jorda; Marcus A Kuczyk; Arnulf Stenzl; Vinata B Lokeshwar
HYAL-1 hyaluronidase: a potential prognostic indicator for progression to muscle invasion and recurrence in bladder cancer.
European urology 2010;57(1):86-93.
2009: Sebastian Attig; Jörg Hennenlotter; Graham Pawelec; Gerd Klein; Sven D Koch; Hanspeter Pircher; Susan Feyerabend; Dorothee Wernet; Arnulf Stenzl; Hans-Georg Rammensee; Cécile Gouttefangeas
Simultaneous infiltration of polyfunctional effector and suppressor T cells into renal cell carcinomas.
Cancer research 2009;69(21):8412-9.
2009: Juliane Sarah Stickel; Andreas O Weinzierl; Nina Hillen; Oliver Drews; Mathias M Schuler; Jörg Hennenlotter; Dorothee Wernet; Claudia A Müller; Arnulf Stenzl; Hans-Georg Rammensee; Stefan Stevanović
HLA ligand profiles of primary renal cell carcinoma maintained in metastases.
Cancer immunology, immunotherapy : CII 2009;58(9):1407-17.
2009: Verena S Meyer; Oliver Drews; Marc Günder; Jörg Hennenlotter; Hans-Georg Rammensee; Stefan Stevanovic
Identification of natural MHC class II presented phosphopeptides and tumor-derived MHC class I phospholigands.
Journal of proteome research 2009;8(7):3666-74.
2009: Susan Feyerabend; Stefan Stevanovic; Cécile Gouttefangeas; Dorothee Wernet; Jörg Hennenlotter; Jens Bedke; Klaus Dietz; Steve Pascolo; Markus Kuczyk; Hans-Georg Rammensee; Arnulf Stenzl
Novel multi-peptide vaccination in Hla-A2+ hormone sensitive patients with biochemical relapse of prostate cancer.
The Prostate 2009;69(9):917-27.
2009: Karl-Dietrich Sievert; Bastian Amend; Udo Nagele; David Schilling; Jens Bedke; Marcus Horstmann; Jörg Hennenlotter; Stephan Kruck; Arnulf Stenzl
Economic aspects of bladder cancer: what are the benefits and costs?
World journal of urology 2009;27(3):295-300.
2009: Karl-Dietrich Sievert; Jörg Hennenlotter; Ines A Laible; Bastian Amend; Udo Nagele; Arnulf Stenzl
The commonly performed nerve sparing total prostatectomy does not acknowledge the actual nerve courses.
The Journal of urology 2009;181(3):1076-81.
2009: Marcus Horstmann; Oliver Patschan; Jörg Hennenlotter; Erika Senger; Gerhard Feil; Arnulf Stenzl
Combinations of urine-based tumour markers in bladder cancer surveillance.
Scandinavian journal of urology and nephrology 2009;43(6):461-6.
2008: Mario Wolfgang Kramer; Markus A Kuczyk; Jörg Hennenlotter; Jürgen Serth; David Schilling; Arnulf Stenzl; Axel S Merseburger
Decreased expression of galectin-3 predicts tumour recurrence in pTa bladder cancer.
Oncology reports 2008;20(6):1403-8.
2008: Axel S Merseburger; Mario W Kramer; Jörg Hennenlotter; Jürgen Serth; Stephan Kruck; Alfredo Gracia; Arnulf Stenzl; Markus A Kuczyk
Loss of galectin-3 expression correlates with clear cell renal carcinoma progression and reduced survival.
World journal of urology 2008;26(6):637-42.
2008: Sabine Conrad; Markus Renninger; Jörg Hennenlotter; Tina Wiesner; Lothar Just; Michael Bonin; Wilhelm Aicher; Hans-Jörg Bühring; Ulrich Mattheus; Andreas Mack; Hans-Joachim Wagner; Stephen Minger; Matthias Matzkies; Michael Reppel; Jürgen Hescheler; Karl-Dietrich Sievert; Arnulf Stenzl; Thomas Skutella
Generation of pluripotent stem cells from adult human testis.
Nature 2008;456(7220):344-9.
2008: Nina Hillen; Gabor Mester; Claudia Lemmel; Andreas O Weinzierl; Margret Müller; Dorothee Wernet; Jörg Hennenlotter; Arnulf Stenzl; Hans-Georg Rammensee; Stefan Stevanović
Essential differences in ligand presentation and T cell epitope recognition among HLA molecules of the HLA-B44 supertype.
European journal of immunology 2008;38(11):2993-3003.
2008: Karl-Dietrich Sievert; Jörg Hennenlotter; Ines Laible; Bastian Amend; David Schilling; Aristotelis G Anastasiadis; Ursula Kuehs; Udo Nagele; Arnulf Stenzl
The periprostatic autonomic nerves--bundle or layer?
European urology 2008;54(5):1109-16.
2008: Arnulf Stenzl; Jörg Hennenlotter; David Schilling
Can we still afford bladder cancer?
Current opinion in urology 2008;18(5):488-92.
2008: Verena Jendrossek; Marco Henkel; Jörg Hennenlotter; Ulrich Vogel; Ute Ganswindt; Ilka Müller; Rene Handrick; Aristoteles G Anastasiadis; Markus Kuczyk; Arnulf Stenzl; Claus Belka
Analysis of complex protein kinase B signalling pathways in human prostate cancer samples.
BJU international 2008;102(3):371-82.
2008: Udo Nagele; Markus A Kuczyk; Marcus Horstmann; Jörg Hennenlotter; Karl-Dietrich Sievert; David Schilling; Ute Walcher; Arnulf Stenzl; Aristotelis G Anastasiadis
Initial clinical experience with full-length metal ureteral stents for obstructive ureteral stenosis.
World journal of urology 2008;26(3):257-62.
2008: Jörg Hennenlotter; Petra A Ohneseit; Perikles Simon; Axel S Merseburger; Jürgen Serth; Ursula Kuehs; Mario Kramer; Joerg T Hartmann; Arnulf Stenzl; Markus A Kuczyk
PTEN and p27Kip1 are not downregulated in the majority of renal cell carcinomas--implications for Akt activation.
Oncology reports 2008;19(5):1141-7.
2008: Bastian Amend; Jörg Hennenlotter; Tobias Schäfer; Marcus Horstmann; Arnulf Stenzl; Karl-Dietrich Sievert
Effective treatment of neurogenic detrusor dysfunction by combined high-dosed antimuscarinics without increased side-effects.
European urology 2008;53(5):1021-8.
2008: Udo Nagele; Aristotelis G Anastasiadis; Axel S Merseburger; Jörg Hennenlotter; Marcus Horstmann; Karl-Dietrich Sievert; Arnulf Stenzl; Markus A Kuczyk
Surgical approach in patients with T4 bladder cancer as primary treatment: Disaster or option with improved quality of life.
Indian journal of urology : IJU : journal of the Urological Society of India 2008;24(1):95-8.
2008: Axel S Merseburger; Jörg Hennenlotter; Ursula Kuehs; Perikles Simon; Stephan Kruck; Eva Koch; Arnulf Stenzl; Markus A Kuczyk
Activation of PI3K is associated with reduced survival in renal cell carcinoma.
Urologia internationalis 2008;80(4):372-7.
2008: Axel S Merseburger; Mario W Kramer; Jörg Hennenlotter; Perikles Simon; Judith Knapp; Jörg Thomas Hartmann; Arnulf Stenzl; Jürgen Serth; Markus A Kuczyk
Involvement of decreased Galectin-3 expression in the pathogenesis and progression of prostate cancer.
The Prostate 2008;68(1):72-7.
2007: Udo Nagele; Marcus Horstmann; Karl-Dietrich Sievert; Markus A Kuczyk; Ute Walcher; Jörg Hennenlotter; Arnulf Stenzl; Aristotelis G Anastasiadis
A newly designed amplatz sheath decreases intrapelvic irrigation pressure during mini-percutaneous nephrolitholapaxy: an in-vitro pressure-measurement and microscopic study.
Journal of endourology / Endourological Society 2007;21(9):1113-6.
2007: Karl-Dietrich Sievert; Aristotelis G Anastasiadis; Jörg Hennenlotter; David Schilling; Axel S Merseburger; Udo Nagele; Matthias P Lichy; Heinz-Peter Schlemmer; A Ulmer; Ulrich Vogel; Karl Sotlar; Markus Kuczyk; Arnulf Stenzl
[The interdisciplinary approach to improve treatment quality of prostate cancer. Optimized nerve sparing in radical prostatectomy].
Der Urologe. Ausg. A 2007;46(9):1104-12.
2007: Karl-Dietrich Sievert; Gerhard Feil; M Renninger; C Selent; Sabine Maurer; Sabine Conrad; Jörg Hennenlotter; Udo Nagele; R Schäfer; R Möhle; Thomas Skutella; Hinnak Northoff; Jörg Seibold; Arnulf Stenzl
[Tissue engineering and stem cell research in urology for a reconstructive or regenerative treatment approach].
Der Urologe. Ausg. A 2007;46(9):1224-30.
2007: Udo Nagele; Aristotelis G Anastasiadis; Axel S Merseburger; Stefan Corvin; Jörg Hennenlotter; Melanie Adam; Karl-Dietrich Sievert; Arnulf Stenzl; Markus A Kuczyk
The rationale for radical cystectomy as primary therapy for T4 bladder cancer.
World journal of urology 2007;25(4):401-5.
2007: P Jacob; Mario H Mueller; J Hahn; I Wolk; Petra Mayer; Udo Nagele; Jörg Hennenlotter; Arnulf Stenzl; Alfred Konigsrainer; Jörg Glatzle
Alterations of neuropeptides in the human gut during peritonitis.
Langenbeck's archives of surgery / Deutsche Gesellschaft für Chirurgie 2007;392(3):267-71.
2007: Karl-Dietrich Sievert; Bastian Amend; M Renninger; C Selent; Gerhard Feil; Jörg Hennenlotter; T Skutella; R Möhle; Hinnak Northoff; Arnulf Stenzl
[Value of stem cell therapy for the treatment of stress incontinence. Current status and perspectives].
Der Urologe. Ausg. A 2007;46(3):264-7.
2007: Mario W Kramer; Axel S Merseburger; Jörg Hennenlotter; Markus Kuczyk
Tissue microarrays in clinical urology--technical considerations.
Scandinavian journal of urology and nephrology 2007;41(6):478-84.
2007: Inga Peters; Kristina Rehmet; Nadine Wilke; Markus A Kuczyk; Jörg Hennenlotter; Tyark Eilers; Stefan Machtens; Udo Jonas; Jürgen Serth
RASSF1A promoter methylation and expression analysis in normal and neoplastic kidney indicates a role in early tumorigenesis.
Molecular cancer 2007;6():49.
2007: Axel S Merseburger; Jörg Hennenlotter; Arnulf Stenzl; Gundhild Beger; Ludwig Rinnab; Markus A Kuczyk; Rainer Kuefer
Cathepsin D serum levels are not a valid serum marker in renal cell carcinoma.
Urologia internationalis 2007;79(1):41-3.
2007: David Schilling; Jörg Hennenlotter; Ulrich Vogel; Udo Nagele; Ulrich Drews; Arnulf Stenzl; Karl-Dietrich Sievert
Giant solitary tumor in the true pelvis: atypical prostatic adenomyomatosis.
Urologia internationalis 2007;78(2):188-92.
2007: Matthias P Lichy; Heinz-Peter Schlemmer; Ulrich Vogel; Jörg Hennenlotter; Claus D Claussen; Arnulf Stenzl; Aristotelis G Anastasiadis
Diagnostic value of MRI in a pelvic mass of prostatic origin: Part 2.
European urology 2007;51(1):273-4.
2007: Andreas O Weinzierl; Claudia Lemmel; Oliver Schoor; Margret Müller; Tobias Krüger; Dorothee Wernet; Jörg Hennenlotter; Arnulf Stenzl; Karin Klingel; Hans-Georg Rammensee; Stefan Stevanovic
Distorted relation between mRNA copy number and corresponding major histocompatibility complex ligand density on the cell surface.
Molecular & cellular proteomics : MCP 2007;6(1):102-13.
2006: Udo Nagele; Marcus Horstmann; Jörg Hennenlotter; Ute Walcher; Markus A Kuczyk; Karl-Dietrich Sievert; Arnulf Stenzl; Aristotelis G Anastasiadis
Size does matter: 1.5 Fr. stone baskets almost double irrigation flow during flexible ureteroscopy compared to 1.9 Fr. stone baskets.
Urological research 2006;34(6):389-92.
2006: Gerhard Feil; Margot Christ-Adler; Sabine Maurer; Stefan Corvin; Hans-Oliver Rennekampff; Jutta Krug; Jörg Hennenlotter; Ursula Kuehs; Arnulf Stenzl; Karl-Dietrich Sievert
Investigations of urothelial cells seeded on commercially available small intestine submucosa.
European urology 2006;50(6):1330-7.
2006: Matthias P Lichy; Heinz-Peter Schlemmer; Ulrich Vogel; Jörg Hennenlotter; Claus D Claussen; Arnulf Stenzl; Aristotelis G Anastasiadis
Diagnostic value of MRI in a pelvic mass of prostatic origin.
European urology 2006;50(6):1357-9.
2006: Axel S Merseburger; Aristotelis G Anastasiadis; Jörg Hennenlotter; D Schilling; Perikles Simon; Stefan Machtens; Jürgen Serth; Arnulf Stenzl; Markus A Kuczyk
Tissue microarrays: applications in urological cancer research.
World journal of urology 2006;24(5):579-84.
2006: Aristotelis G Anastasiadis; Matthias P Lichy; Udo Nagele; Markus A Kuczyk; Axel S Merseburger; Jörg Hennenlotter; Stefan Corvin; Karl-Dietrich Sievert; Claus D Claussen; Arnulf Stenzl; Heinz-Peter Schlemmer
MRI-guided biopsy of the prostate increases diagnostic performance in men with elevated or increasing PSA levels after previous negative TRUS biopsies.
European urology 2006;50(4):738-48; discussion 748-9.
2006: Jörn Dengjel; Maria-Dorothea Nastke; Cécile Gouttefangeas; Gitsios Gitsioudis; Oliver Schoor; Florian Altenberend; Margret Müller; Björn Krämer; Anna Missiou; Martina Sauter; Jörg Hennenlotter; Dorothee Wernet; Arnulf Stenzl; Hans-Georg Rammensee; Karin Klingel; Stefan Stevanović
Unexpected abundance of HLA class II presented peptides in primary renal cell carcinomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(14 Pt 1):4163-70.
2006: Axel S Merseburger; Jörg Hennenlotter; Perikles Simon; Carolin C Müller; Ursula Kühs; Ruth Knüchel-Clarke; Judd W Moul; Arnulf Stenzl; Markus A Kuczyk
Activation of the PKB/Akt pathway in histological benign prostatic tissue adjacent to the primary malignant lesions.
Oncology reports 2006;16(1):79-83.
2006: Axel S Merseburger; Jörg Hennenlotter; D Schilling; Karl-Dietrich Sievert; Rainer Küfer; Markus A Kuczyk
[Application of tissue microarrays for the diagnosis, prognosis and therapeutic decision making in renal cell carcinoma].
Der Urologe. Ausg. A 2006;45(3):323-4, 326-7.
2006: Stefan Corvin; David Schilling; Kai Eichhorn; Ilse Hundt; Jörg Hennenlotter; Aristotelis G Anastasiadis; Markus Kuczyk; Roland Bares; Arnulf Stenzl
Laparoscopic sentinel lymph node dissection--a novel technique for the staging of prostate cancer.
European urology 2006;49(2):280-5.
2006: Jonathan Tolson; Thomas Flad; Volker Gnau; Hassan Dihazi; Jörg Hennenlotter; Alexander Beck; Gerhard A Mueller; Markus Kuczyk; Claudia Mueller
Differential detection of S100A8 in transitional cell carcinoma of the bladder by pair wise tissue proteomic and immunohistochemical analysis.
Proteomics 2006;6(2):697-708.
2005: Marcus Horstmann; Axel S Merseburger; E von der Heyde; Jürgen Serth; Gerd Wegener; Michael Mengel; Gerhard Feil; Jörg Hennenlotter; Udo Nagele; Aristotelis G Anastasiadis; Carsten Bokemeyer; Arnulf Stenzl; Markus Kuczyk
Correlation of bFGF expression in renal cell cancer with clinical and histopathological features by tissue microarray analysis and measurement of serum levels.
Journal of cancer research and clinical oncology 2005;131(11):715-22.
2005: Axel S Merseburger; Jörg Hennenlotter; Perikles Simon; Petra A Ohneseit; Ursula Kuehs; Stephan Kruck; Eva Koch; Ulrich Vogel; Arnulf Stenzl; Markus A Kuczyk
Cathepsin D expression in renal cell cancer-clinical implications.
European urology 2005;48(3):519-26.
2005: Björn F Krämer; Oliver Schoor; Tobias Krüger; Christian Reichle; Margret Müller; Toni Weinschenk; Jörg Hennenlotter; Arnulf Stenzl; Hans-Georg Rammensee; Stefan Stevanovic
MAGED4-expression in renal cell carcinoma and identification of an HLA-A*25-restricted MHC class I ligand from solid tumor tissue.
Cancer biology & therapy 2005;4(9):943-8.
2005: Tobias Krüger; Oliver Schoor; Claudia Lemmel; Bjoern Kraemer; Christian Reichle; Jörn Dengjel; Toni Weinschenk; Margret Müller; Jörg Hennenlotter; Arnulf Stenzl; Hans-Georg Rammensee; Stefan Stevanović
Lessons to be learned from primary renal cell carcinomas: novel tumor antigens and HLA ligands for immunotherapy.
Cancer immunology, immunotherapy : CII 2005;54(9):826-36.
2005: Karl-Dietrich Sievert; C-G Xiao; Jörg Hennenlotter; Jörg Seibold; Axel S Merseburger; J Kaminskie; Udo Nagele; Arnulf Stenzl
[Voluntary micturition after intradural nerve anastomosis].
Der Urologe. Ausg. A 2005;44(7):756-61.
2005: Axel S Merseburger; Jörg Hennenlotter; Perikles Simon; Stephan Kruck; Eva Koch; Marcus Horstmann; Ursula Kuehs; Rainer Küfer; Arnulf Stenzl; Markus A Kuczyk
Membranous expression and prognostic implications of epidermal growth factor receptor protein in human renal cell cancer.
Anticancer research 2005;25(3B):1901-7.
2005: Matthias P Lichy; Jörg Pintaske; Raimund Kottke; Jürgen Machann; Aristotelis G Anastasiadis; Stefan Roell; Jörg Hennenlotter; Till Diergarten; Fritz Schick; Arnulf Stenzl; Claus D Claussen; Heinz-Peter Schlemmer
3D proton MR spectroscopic imaging of prostate cancer using a standard spine coil at 1.5 T in clinical routine: a feasibility study.
European radiology 2005;15(4):653-60.
2003: Oliver Schoor; Toni Weinschenk; Jörg Hennenlotter; Stefan Corvin; Arnulf Stenzl; Hans-Georg Rammensee; Stefan Stevanović
Moderate degradation does not preclude microarray analysis of small amounts of RNA.
BioTechniques 2003;35(6):1192-6, 1198-201.
2003: Gerhard Feil; Karl-Horst Bichler; H J Päulgen-Nelde; Jörg Hennenlotter; Andreas Zumbrägel; Arnulf Stenzl
[ImmunoCyt--a new urine test in diagnosis of bladder cancer].
Der Urologe. Ausg. A 2003;42(4):531-7.
2003: Gerhard Feil; Andreas Zumbrägel; Hans J Päulgen-Nelde; Jörg Hennenlotter; Sabine Maurer; Stefen Krause; Karl-Horst Bichler; Arnulf Stenzl
Accuracy of the ImmunoCyt assay in the diagnosis of transitional cell carcinoma of the urinary bladder.
Anticancer research 2003;23(2A):963-7.